My hunch is it is to do with XV Ventilation (XV) FDA approval forward from it's clearance in Mar 2020 OR maybe a early TGA pre submission update OR maybe regulatory approval in another part of the world. However I'm a bit confused as 4dx is implementing a SaaS model rather than an actual "medical device" as such.
Unless someone can shed more light around this space.
Ann: Trading Halt, page-6
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
-0.010(2.27%) |
Mkt cap ! $176.5M | |||
| Open | High | Low | Value | Volume |
| 44.5¢ | 45.0¢ | 42.5¢ | $218.0K | 499.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90203 | 43.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.0¢ | 4379 | 2 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |